The Global Fund's China Legacy. Huang Y and Ping J. (2014)

immage

Over the past decade, the Global Fund's presence in China has left behind a deeply mixed legacy. Although the Fund's money has made important contributions to China's fight against AIDS, TB, and malaria, as well as its domestic health governance in ideational, institutional, and policy domains, it is associated with uneven progress in grant performance, low value for money, unintended effects on civil society–building, and enduring challenges to scaling-up and sustainability.

 

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Papua New Guinea. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

The Trans-Pacific Partnership Agreement: Implications for Access to Medicines and Public Health. Bhardwaj K and Oh C. (2014)

immage

The objective of this report is to provide an analysis of the provisions in the proposed TPPA in order to obtain a clearer understanding of their implications. It is hoped that the report will also be a useful resource for other stakeholders in the public health field.

 

The report analyses the key negotiating issues in the USA’s proposals (widely considered to be the basic negotiation text for the TPPA) which are likely to have an impact on access to medicines and public health.

 

Analysis in this report is based on negotiation texts that were leaked and made available in the public domain in 2011 and 2012. The main texts include the USA’s proposals for chapters on intellectual property, on the regulation of pharmaceutical reimbursement programmes and on investment. It should be borne in mind that it may not be possible to provide a comprehensive examination of all relevant provisions or to assess fully how these provisions will impact and interact with other parts of the TPPA (which are not currently in the public domain). Moreover, as long as the negotiations are ongoing, the text may evolve and change.

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Sri Lanka. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

The Funding Crisis for Harm Reduction: Donor Retreat, Government Neglect and the Way forward The Global. Cook C, Bridge J, McLean S, et al. (2014)

immage

Funding for HIV-related harm reduction programmes globally is in crisis. There can be no ‘AIDS free generation’ without targeted efforts with and for people who inject drugs, yet, as this report shows, funding for harm reduction falls dangerously short of estimated need. As a result, coverage of essential HIV and harm reduction programmes targeting people who inject drugs is very low and wholly inadequate to respond effectively to HIV among this community. While this has been the case for some time, the data and policy analysis conducted for this report shows that rather than action being taken to address this problem, the situation looks set to deteriorate.

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Thailand. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Afghanistan. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Vietnam. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

Fact Sheet: Investing in Sexual and Reproductive Health in Asia. UNFPA and Guttmacher Institute. (2014)

immage

Sexual and reproductive health services enable women and couples to have the number of children they want, when they want them; to deliver their babies safely and have healthy newborns; and to have healthy sexual lives, free from HIV and other sexually transmitted infections (STIs).

 

Keywords: HIV, maternal health, human rights, investments, cost-effectiveness

Download Publication

MSM and Transgender Engagement in Global Fund New Funding Model Country Dialogue in Bangladesh. APCOM. (2014)

immage In 2014, the Global Fund’s New Funding Model (NFM) will begin operating. Inclusiveness of civil society and key affected populations (KAP) (including men who have sex with men (MSM) and transgender people) is a key feature of the NFM. It is also one of the main criteria in assessing whether funding applications are robust. Country Dialogue is the term used by the Global Fund to describe the inclusive, ongoing consultative processes at the country level that is meant to inform all stages of the NFM process. Therefore, the country dialogue process presents a significant opportunity for civil society organisations representing MSM and transgender people to be meaningfully involved in all the stages of the NFM.
Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
https://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events